Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

Fig. 1

Association of ADA status at follow-up with baseline clinical indication for treatment and immunological features. a Frequency of ADA positivity at follow-up is significantly higher in SLE patients treated for lupus nephritis (LN) with respect to other clinical manifestations (non-LN), Fisher exact test, p = 0.001. b ADA positivity at follow-up is associated with the presence of positive anti-dsDNA at baseline, Fisher exact text, p = 0.03.c No significant association of complement (C) activation at baseline with positive ADA status at follow-up (chi-square test)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us